111 (YI) Stock: Buy, Sell, or Hold?
YI - 111, Inc. American Depositary Shares
$3.22
-0.08 (-2.57%)
βΌ
5d:
-10.56%
30d:
-7.47%
90d:
-25.81%
WAIT
LOW Confidence
Analysis Updated: Oct 2, 2026 12:00 AM ET
Earnings: Sep 16, 2026
0d
Get Alerted When YI Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
βΈοΈ WAIT FOR STABILIZATION: YI is down 10.6% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
βΈοΈ WAIT FOR STABILIZATION: YI is down 10.6% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
In-depth Analysis How we analyze
Valuation Analysis: YI is currently trading at $3.22, which is considered oversold relative to its 30-day fair value range of $3.31 to $3.64.
Technical Outlook: Technically, YI is in a strong downtrend. The price is currently testing key support at $3.21. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: YI scores 28/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $5.96 (+85.1%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, YI is in a strong downtrend. The price is currently testing key support at $3.21. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: YI scores 28/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $5.96 (+85.1%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$3.31 -
$3.64
Company Quality Score
37/100
(SELL)
Volume Confirmation
HIGH
Confidence Score
57.9%
All Signals
- BULLISH: Price oversold vs 30-day range
- BEARISH: Weak technical setup (28/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 85.1% below Wall St target ($5.96)
- WARNING: Composite score 37/100 in the bottom quintile β this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$3.31 -
$3.64
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$3.21
Resistance Level
$4.08
Current Trend
Strong Downtrend
Technical data as of
Oct 2, 2026
Fundamental Context
Wall Street Target
$5.96
(+85.1%)
Revenue Growth (YoY)
-28.3%
Profit Margin
-1.0%
Share & Embed Analysis
Last updated: October 03, 2026 1:50 AM ET
Data refreshes hourly during market hours. Next update: 2:50 AM
Data refreshes hourly during market hours. Next update: 2:50 AM
π₯ Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is YI showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Distribution Stocks
Top-rated stocks in Medical Distribution by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
MCK
McKesson Corporation |
STRONG BUY
17 analysts |
$979 | 64 BUY |
|
CAH
Cardinal Health Inc |
BUY
17 analysts |
$270 | 70 BUY |
|
COR
Cencora Inc. |
STRONG BUY
14 analysts |
$369 | 62 BUY |
|
HSIC
Henry Schein Inc |
HOLD
16 analysts |
$97 | 56 HOLD |
|
QIPT
Quipt Home Medical Corp |
STRONG BUY
5 analysts |
$4 | 52 HOLD |